期刊文献+

迈进儿童血友病关怀新时代 被引量:3

Entry into the new era of care for children with hemophilia
原文传递
导出
摘要 血友病诊治得益于科学的进步,作为一种可以致死、致残的先天性凝血异常性疾病,血友病的关怀事业正在不断进步。目前,血友病已从一种威胁生命的疾病转变为终生携带的疾病,临床已看到了治愈的曙光。世界范围内儿童血友病关怀事业面临的主要问题是如何更加合理有效地开展预防治疗、如何有效防控抑制物。而随着血友病关怀领域不断涌现的创新性、革命性的新技术及产品,血友病的关怀理念和策略面临不断更新和挑战。中国作为发展中国家,虽然儿童血友病关怀起步较晚,但进展较快。应用更加个性化的治疗和新的技术产品,中国儿童血友病关怀事业将进入新的时代。 Thanks to the development of science, hemophilia care is improved gradually, and hemophilia is turning ti'om one of inherited bleeding diseases with death and disability into one of lifelong diseases and it' s likely to deal with suc- cessfully in clinics. At present, the main problems of children hemophilia care are how to cost-effectively execute the pro- phylaxis and how to prevent and control the inhibitor. With the creation of novel technologies and products in hemophilia care, the conceptions and strategies of care are facing updating and challenges. Although China is a developing country and is slow in starting the care, the development of Children Hemophilia Care has improved rapidly. With the more indi- vidualized treatment and novel technologies and products, the Children Hemophilia Care will enter a new era.
出处 《中国实用儿科杂志》 CSCD 北大核心 2017年第1期18-22,共5页 Chinese Journal of Practical Pediatrics
关键词 儿童 血友病 综合关怀 child hemophilia comprehensive care
  • 相关文献

参考文献1

二级参考文献10

  • 1SRIVASTAVA A,BREWER AK, MAUSER- BUNSCHOTENE P, et al. Guidelines for the management of Hemophilia.Haemophilia ,2012 ; 1-47.
  • 2LJUNG RC. Prophylactic treatment in Sweden-overtreatmentor optimal model? [ J ]. Haemophilia, 1998,4 (4): 409-412.
  • 3FISCHER K,ASTERMARK J,VAN DER BOM JG,ET AL.PROPHYLACTIC TREATMENT FOR SEVERE HAEMO-PHILIA : COMPArison of an intermediate- dose to a high-dose regimen[ J]. Haemophilia,2002,8(6) :753-760.
  • 4HILLIARD P, ZOURIKIAN N, BLANCHETTE V,et al.Musculoskeletal health of subjects with hemophilia A treatedwith tailored prophylaxis : Canadian Hemophilia PrimaryProphylaxis ( CHPS) Study [ J ]. J Thromb Haemost,2013,11(3):460-466.
  • 5RISEBROUGH N,OH P,BLANCHETTE V,et al. Cost-utili-ty analysis of Canadian tailored prophylaxis,primary prophy-laxis and on- demand therapy in young children with severehaemophilia A[ J]. Haemophilia,2008,14(4) :743-752.
  • 6S. LALEZARI,U. MARTINOWITZ, J. WINDYGA, M. M.ENRIQUEZ, H. DELESEN,L. SCHWARTZ AND I.SCHARRER. Correlation between endogenous VWF: Ag andPK parameters and bleeding frequency in severe haemophiliaA subjects during three-times-weekly prophylaxis with rFVI-II- FS Haemophilia (2014) , 20, e15- e22.
  • 7L. A. VALENTINO. Considerations in individualizing proph-ylaxis in patients with haemophilia A Haemophilia (2014),1-9.
  • 8Blanchette. Definitions in hemophilia: communication fromthe SSC of the ISTH. Accepted Article’ .
  • 9WU RH,LUKE KH,POON MC,WU X,ZHANG N,ZHAOL,et al. Low dose secondary prophylaxis reduces joint bleed-ing in severe and moderate hemophilia children : a pilot studyin China. Haemophilia,2011,17,70-74.
  • 10K. LINDVALL, et al. Daily dosing prophylaxis for haemo-philia :a randomized crossover pilot study evaluating feasibil-ity and efficacy. Haemophilia(2012) ,18,855-859.

共引文献1

同被引文献17

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部